Stay updated on NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial
Sign up to get notified when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.

Latest updates to the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updates include a new revision label (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure link and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe Record History now shows Revision: v3.3.2 as the current version, replacing v3.3.1. No study details or page behavior appear to be affected.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page history now shows a new revision entry v3.3.1, and the previous entry v3.2.0 is removed, reflecting an administrative update to the history.SummaryDifference0.1%

- Check49 days agoChange DetectedAn administrative notice about potential delays in updates due to funding is now displayed and does not modify study data or records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedThe two screenshots reflect small presentation adjustments on the Record History page without changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference9%

Stay in the know with updates to NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NEURO-TTRansform: Eplontersen Efficacy in HATTR Clinical Trial page.